Clin2
NCT06648681Possibly a fitNot yet recruiting

Lemborexant to prevent confusion after heart surgery

Delirium - PostoperativeCardiac SurgeryCardiac Surgery SubjectsOrexin AntagonistFeasibility StudiesSleepIn-hospital Mortality

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests if lemborexant, a sleep medication, can help prevent confusion (delirium) after open-heart surgery. If you are having heart surgery through a chest incision, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
61 years and older
Study type
Interventional

Who can take part

  • You are admitted to the hospital after open-heart surgery through the middle of your chest.
  • You do not have severe sleep apnea (a condition where breathing stops during sleep) or related sleep disorders.
  • You are not currently struggling with alcohol or drug misuse.
  • You are not taking certain medications that affect the study drug.
  • You do not have severe liver or kidney problems, or a very high body mass index (BMI > 40).
  • You are able to communicate in English.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06496282Recruiting· Phase 3
Lemborexant for better sleep in shift workers

This study tests a sleep medication called lemborexant to see if it helps people who work rotating shifts sleep better and feel less sleepy during their shifts.

Ratchathewi, Bangkok
NCT06262594Recruiting· Phase 3
Testing a sleep medicine for epilepsy-related insomnia

This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.

Durham, North Carolina
NCT06981195Recruiting· Phase 2
Testing lemborexant for insomnia in people on buprenorphine

This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.

Richmond, Virginia
NCT06756178Not yet recruiting· Early Phase 1
Comparing two sedatives to prevent delirium after heart surgery

This trial tests whether a newer sedative (remimazolam) or a commonly used one (dexmedetomidine) is better at preventing delirium after planned heart surgery that requires a heart-lung machine. If you are having elective coronary bypass or valve surgery, you may be able to join.

Asyut
NCT06721819Recruiting· Phase 3
Sleep and brain training before heart surgery to prevent delirium

This study tests whether a combination of sleep therapy, brain games, and light exercise before heart surgery can help prevent confusion or disorientation (delirium) after the operation. Participants will be asked to use a tablet and fitness tracker daily for about an hour before their surgery.

Boston, Massachusetts
NCT07695285Not yet recruiting· Phase 2
Lemborexant for improving thinking after confusion in older surgery patients

This trial tests if lemborexant can help older adults recover their thinking abilities after experiencing confusion following surgery. It compares lemborexant to a placebo to see if it improves cognitive function.

Hear when a new Cardiac Surgery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.